NVO logo

Novo Nordisk A/S (NVO) Gross profit

Annual gross profit:

$35.31B+$7.24B(+25.81%)
December 31, 2024

Summary

  • As of today (August 20, 2025), NVO annual gross profit is $35.31 billion, with the most recent change of +$7.24 billion (+25.81%) on December 31, 2024.
  • During the last 3 years, NVO annual gross profit has risen by +$16.95 billion (+92.35%).
  • NVO annual gross profit is now at all-time high.

Performance

NVO Gross profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVOincome statement metrics

quarterly gross profit:

$9.73B+$532.91M(+5.79%)
June 1, 2025

Summary

  • As of today (August 20, 2025), NVO quarterly gross profit is $9.73 billion, with the most recent change of +$532.91 million (+5.79%) on June 1, 2025.
  • Over the past year, NVO quarterly gross profit has increased by +$1.39 billion (+16.69%).
  • NVO quarterly gross profit is now -6.35% below its all-time high of $10.39 billion, reached on December 31, 2024.

Performance

NVO quarterly gross profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVOincome statement metrics

TTM gross profit:

$38.16B+$1.39B(+3.79%)
June 1, 2025

Summary

  • As of today (August 20, 2025), NVO TTM gross profit is $38.16 billion, with the most recent change of +$1.39 billion (+3.79%) on June 1, 2025.
  • Over the past year, NVO TTM gross profit has increased by +$6.54 billion (+20.68%).
  • NVO TTM gross profit is now at all-time high.

Performance

NVO TTM gross profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVOincome statement metrics

Gross profit Formula

Gross Profit = Revenue − Cost Of Goods Sold

NVO Gross profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+25.8%+16.7%+20.7%
3 y3 years+92.3%+93.3%+91.3%
5 y5 years+133.6%+161.2%+143.3%

NVO Gross profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+92.3%-6.3%+93.3%at high+91.3%
5 y5-yearat high+133.6%-6.3%+161.2%at high+143.3%
alltimeall timeat high>+9999.0%-6.3%>+9999.0%at high>+9999.0%

NVO Gross profit History

DateAnnualQuarterlyTTM
Jun 2025
-
$9.73B(+5.8%)
$38.16B(+3.8%)
Mar 2025
-
$9.20B(-11.5%)
$36.76B(+3.2%)
Dec 2024
$35.31B(+25.8%)
$10.39B(+17.6%)
$35.63B(+7.0%)
Sep 2024
-
$8.84B(+5.9%)
$33.30B(+5.3%)
Jun 2024
-
$8.34B(+3.3%)
$31.62B(+5.2%)
Mar 2024
-
$8.07B(+0.2%)
$30.06B(+5.5%)
Dec 2023
$28.07B(+36.1%)
$8.05B(+12.6%)
$28.51B(+10.0%)
Sep 2023
-
$7.15B(+5.4%)
$25.91B(+8.2%)
Jun 2023
-
$6.78B(+4.2%)
$23.95B(+7.9%)
Mar 2023
-
$6.51B(+19.3%)
$22.20B(+5.8%)
Dec 2022
$20.62B(+12.3%)
$5.46B(+5.2%)
$20.98B(+2.6%)
Sep 2022
-
$5.19B(+3.1%)
$20.45B(+2.5%)
Jun 2022
-
$5.04B(-4.9%)
$19.95B(+3.0%)
Mar 2022
-
$5.29B(+7.3%)
$19.37B(+4.1%)
Dec 2021
$18.36B(+15.6%)
$4.93B(+5.3%)
$18.61B(+3.8%)
Sep 2021
-
$4.69B(+5.1%)
$17.92B(+3.7%)
Jun 2021
-
$4.46B(-1.7%)
$17.28B(+4.4%)
Mar 2021
-
$4.53B(+6.7%)
$16.55B(+2.1%)
Dec 2020
$15.88B(+5.1%)
$4.25B(+5.0%)
$16.22B(+1.6%)
Sep 2020
-
$4.05B(+8.6%)
$15.97B(+1.9%)
Jun 2020
-
$3.73B(-11.3%)
$15.68B(-0.4%)
Mar 2020
-
$4.20B(+5.0%)
$15.74B(+3.0%)
Dec 2019
$15.12B(+2.8%)
$4.00B(+6.5%)
$15.28B(+1.1%)
Sep 2019
-
$3.75B(-0.9%)
$15.12B(+0.7%)
Jun 2019
-
$3.79B(+1.4%)
$15.00B(+0.7%)
Mar 2019
-
$3.74B(-2.6%)
$14.90B(-0.1%)
Dec 2018
$14.71B(+3.8%)
$3.84B(+5.3%)
$14.92B(+1.0%)
Sep 2018
-
$3.64B(-1.2%)
$14.76B(+0.8%)
Jun 2018
-
$3.69B(-1.8%)
$14.65B(+0.7%)
Mar 2018
-
$3.75B(+1.8%)
$14.55B(+2.0%)
Dec 2017
$14.17B(+1.4%)
$3.68B(+4.4%)
$14.27B(+0.8%)
Sep 2017
-
$3.53B(-1.6%)
$14.16B(-0.0%)
Jun 2017
-
$3.59B(+3.4%)
$14.16B(+0.2%)
Mar 2017
-
$3.47B(-2.9%)
$14.13B(+0.5%)
Dec 2016
$13.98B(+3.0%)
$3.57B(+1.1%)
$14.05B(+0.1%)
Sep 2016
-
$3.53B(-0.6%)
$14.04B(+0.8%)
Jun 2016
-
$3.55B(+4.7%)
$13.93B(+0.8%)
Mar 2016
-
$3.40B(-4.6%)
$13.81B(+1.3%)
Dec 2015
$13.57B(+3.5%)
$3.56B(+4.2%)
$13.64B(+0.8%)
Sep 2015
-
$3.42B(-0.6%)
$13.53B(+0.5%)
Jun 2015
-
$3.44B(+6.9%)
$13.46B(+1.0%)
Mar 2015
-
$3.22B(-6.9%)
$13.32B(+0.9%)
Dec 2014
$13.11B(+7.0%)
$3.46B(+3.3%)
$13.20B(+0.9%)
Sep 2014
-
$3.35B(+1.4%)
$13.08B(+2.6%)
Jun 2014
-
$3.30B(+6.5%)
$12.75B(+1.5%)
Mar 2014
-
$3.10B(-7.2%)
$12.57B(+1.6%)
Dec 2013
$12.26B(+11.0%)
$3.34B(+10.7%)
$12.37B(+2.0%)
Sep 2013
-
$3.02B(-3.1%)
$12.12B(+2.3%)
Jun 2013
-
$3.11B(+7.4%)
$11.85B(+3.0%)
Mar 2013
-
$2.90B(-6.4%)
$11.51B(+3.3%)
Dec 2012
$11.04B(+11.3%)
$3.10B(+12.7%)
$11.14B(+3.5%)
Sep 2012
-
$2.75B(-0.7%)
$10.76B(+2.2%)
Jun 2012
-
$2.77B(+9.3%)
$10.53B(+2.7%)
Mar 2012
-
$2.53B(-6.9%)
$10.25B(+2.2%)
Dec 2011
$9.92B(+15.0%)
$2.72B(+7.9%)
$10.03B(+3.5%)
Sep 2011
-
$2.52B(+1.1%)
$9.69B(+3.4%)
Jun 2011
-
$2.49B(+7.9%)
$9.36B(+4.1%)
Mar 2011
-
$2.31B(-2.7%)
$8.99B(+3.1%)
Dec 2010
$8.62B(+14.9%)
$2.37B(+8.2%)
$8.73B(+3.6%)
Sep 2010
-
$2.19B(+3.5%)
$8.42B(+3.8%)
Jun 2010
-
$2.12B(+3.9%)
$8.12B(+2.8%)
Mar 2010
-
$2.04B(-1.4%)
$7.90B(+3.9%)
DateAnnualQuarterlyTTM
Dec 2009
$7.50B(+8.9%)
$2.07B(+9.6%)
$7.60B(+4.0%)
Sep 2009
-
$1.89B(-0.6%)
$7.31B(+2.1%)
Jun 2009
-
$1.90B(+8.8%)
$7.16B(+1.5%)
Mar 2009
-
$1.75B(-1.7%)
$7.05B(+1.4%)
Dec 2008
$6.89B(+18.6%)
$1.78B(+2.1%)
$6.95B(+2.3%)
Sep 2008
-
$1.74B(-2.9%)
$6.80B(+4.0%)
Jun 2008
-
$1.79B(+8.7%)
$6.53B(+4.9%)
Mar 2008
-
$1.65B(+1.7%)
$6.23B(+5.6%)
Dec 2007
$5.81B(+19.5%)
$1.62B(+9.9%)
$5.90B(+4.5%)
Sep 2007
-
$1.47B(-0.7%)
$5.65B(+4.4%)
Jun 2007
-
$1.49B(+12.7%)
$5.41B(+4.3%)
Mar 2007
-
$1.32B(-3.5%)
$5.18B(+5.4%)
Dec 2006
$4.86B(+19.7%)
$1.37B(+10.4%)
$4.92B(+5.7%)
Sep 2006
-
$1.24B(-1.8%)
$4.65B(+4.2%)
Jun 2006
-
$1.26B(+19.8%)
$4.47B(+5.6%)
Mar 2006
-
$1.05B(-4.3%)
$4.23B(+3.5%)
Dec 2005
$4.06B(+15.6%)
$1.10B(+4.5%)
$4.09B(+2.3%)
Sep 2005
-
$1.05B(+2.5%)
$4.00B(+4.7%)
Jun 2005
-
$1.03B(+12.6%)
$3.82B(+5.0%)
Mar 2005
-
$910.99M(-9.6%)
$3.64B(+3.7%)
Dec 2004
$3.51B(+23.2%)
$1.01B(+15.4%)
$3.51B(+8.9%)
Sep 2004
-
$874.01M(+3.4%)
$3.22B(+6.3%)
Jun 2004
-
$844.97M(+8.1%)
$3.03B(+6.3%)
Mar 2004
-
$781.88M(+8.4%)
$2.85B(+7.1%)
Dec 2003
$2.85B(+23.9%)
$721.59M(+5.5%)
$2.66B(+5.0%)
Sep 2003
-
$683.99M(+2.8%)
$2.54B(+3.9%)
Jun 2003
-
$665.20M(+12.0%)
$2.44B(+4.3%)
Mar 2003
-
$593.78M(-0.2%)
$2.34B(+6.8%)
Dec 2002
$2.30B(+9.7%)
$595.12M(+0.9%)
$2.19B(+37.2%)
Sep 2002
-
$589.79M(+4.5%)
$1.60B(+58.4%)
Jun 2002
-
$564.62M(+26.8%)
$1.01B(+126.8%)
Mar 2002
-
$445.42M(>+9900.0%)
$445.42M(>+9900.0%)
Dec 2001
$2.10B(+10.2%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2001
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2001
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2001
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2000
$1.90B(-4.9%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2000
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2000
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2000
-
$0.00(0.0%)
$0.00(0.0%)
Dec 1999
$2.00B(+16.7%)
-
-
Sep 1999
-
$0.00(0.0%)
$0.00(0.0%)
Jun 1999
-
$0.00(0.0%)
$0.00(0.0%)
Mar 1999
-
$0.00
$0.00
Dec 1998
$1.71B(+6.1%)
-
-
Dec 1997
$1.62B(+1.0%)
-
-
Dec 1996
$1.60B(+6.8%)
-
-
Dec 1995
$1.50B(+16.6%)
-
-
Dec 1994
$1.28B(+137.7%)
-
-
Dec 1993
$540.32M(+3.6%)
-
-
Dec 1992
$521.66M(+23.7%)
-
-
Dec 1991
$421.71M(+26.0%)
-
-
Dec 1990
$334.68M(+29.9%)
-
-
Dec 1989
$257.72M(+26.3%)
-
-
Dec 1988
$204.00M(+180.3%)
-
-
Dec 1987
$72.79M(-4.6%)
-
-
Dec 1986
$76.29M(+18.2%)
-
-
Dec 1985
$64.53M(-14.6%)
-
-
Dec 1984
$75.56M(-17.9%)
-
-
Dec 1983
$92.09M(+36.3%)
-
-
Dec 1982
$67.54M(-0.1%)
-
-
Dec 1981
$67.59M(+25.9%)
-
-
Dec 1980
$53.69M
-
-

FAQ

  • What is Novo Nordisk A/S annual gross profit?
  • What is the all time high annual gross profit for Novo Nordisk A/S?
  • What is Novo Nordisk A/S annual gross profit year-on-year change?
  • What is Novo Nordisk A/S quarterly gross profit?
  • What is the all time high quarterly gross profit for Novo Nordisk A/S?
  • What is Novo Nordisk A/S quarterly gross profit year-on-year change?
  • What is Novo Nordisk A/S TTM gross profit?
  • What is the all time high TTM gross profit for Novo Nordisk A/S?
  • What is Novo Nordisk A/S TTM gross profit year-on-year change?

What is Novo Nordisk A/S annual gross profit?

The current annual gross profit of NVO is $35.31B

What is the all time high annual gross profit for Novo Nordisk A/S?

Novo Nordisk A/S all-time high annual gross profit is $35.31B

What is Novo Nordisk A/S annual gross profit year-on-year change?

Over the past year, NVO annual gross profit has changed by +$7.24B (+25.81%)

What is Novo Nordisk A/S quarterly gross profit?

The current quarterly gross profit of NVO is $9.73B

What is the all time high quarterly gross profit for Novo Nordisk A/S?

Novo Nordisk A/S all-time high quarterly gross profit is $10.39B

What is Novo Nordisk A/S quarterly gross profit year-on-year change?

Over the past year, NVO quarterly gross profit has changed by +$1.39B (+16.69%)

What is Novo Nordisk A/S TTM gross profit?

The current TTM gross profit of NVO is $38.16B

What is the all time high TTM gross profit for Novo Nordisk A/S?

Novo Nordisk A/S all-time high TTM gross profit is $38.16B

What is Novo Nordisk A/S TTM gross profit year-on-year change?

Over the past year, NVO TTM gross profit has changed by +$6.54B (+20.68%)
On this page